Quantcast

Latest Ribbon symbolism Stories

2014-04-08 12:31:44

Metronomic algorithms for targeted therapy to improve value of response and "failed drugs" for "resistant women's cancers" NEW YORK, April 8, 2014 /PRNewswire/ -- The following will be presented this week at the annual meeting of the American Association of Cancer Research, San Diego. Dr Howard Bruckner will present accumulating evidence describing a novel successful treatment for patients with resistant ovarian cancer. Low dose chemotherapy as cores, selected drug combinations,...

2014-04-08 08:31:39

OICR's catalyst grant enables WaveCheck to open first partner site at MD Anderson Cancer Center in May TORONTO, April 8, 2014 /PRNewswire/ - People with breast cancer are a step closer to knowing if their tumour is responding to chemotherapy at the start of treatment, thanks to a $100,000 catalyst grant from the Ontario Institute for Cancer Research (OICR). The funding builds upon MaRS Innovation's Indiegogo crowdfunding campaign for WaveCheck, which successfully raised over...

2014-04-07 16:35:29

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna: "We found that for each Gray delivered to the lung as part of radiotherapy for a breast tumour, the relative risk of...

2014-04-07 16:10:23

A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive. Now, researchers at the Stanford University School of Medicine have devised a way to quickly bring...

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...

2014-04-07 12:40:36

Obese male mice and normal weight female mice produce female pups that are overweight at birth and in childhood, and have increased number of "terminal end buds" in their breast tissue — the site where cancer often develops in rodents. The findings, presented by a Georgetown Lombardi Comprehensive Cancer Center researcher at the AACR Annual Meeting 2014, come from one of the first animal studies to examine the impact of paternal obesity on future generations' cancer risk. In addition,...

2014-04-07 12:33:35

The Most Promising Emerging Agents in Development for Triple Negative Breast Cancer Target Only Specific Patient Subsets, According to Findings from Decision Resources Group BURLINGTON, Mass., April 7, 2014 /PRNewswire/ -- Decision Resources Group finds that due to the heterogeneity of triple negative breast cancer the most promising emerging agents in development, target only specific subsets of patients. The two novel emerging therapies niraparib (Tesaro) and Xtandi (Medivation/Astellas)...

2014-04-06 12:20:19

INDIANAPOLIS, April 6, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present early-stage data from several targeted cancer therapies - including bemaciclib "beh meh sye' klib" (LY2835219), its oral, cell-cycle inhibitor of CDK4/6 - that make up its diverse clinical oncology pipeline during the American Association for Cancer Research (AACR) Annual Meeting 2014 held in San Diego, Calif. from April 5 - 9. "Harnessing Breakthroughs - Targeting Cures" is the theme of this year's...

2014-04-05 23:01:13

RF Safe's pink cell phone radiation shields are great for supporting fundraising events for breast cancer awareness. Doctors say keeping cell phones tucked in bras possibly causes breast cancer in young women. Boston, MA (PRWEB) April 05, 2014 RF Safe claims a research team, led by Dr. Lisa Bailey, and one of California’s top breast surgeons, studied four young women – aged from 21 to 39 years old – with multifocal invasive breast cancer that appears to be caused from cell phone...

2014-04-04 23:40:49

Dr. Vera Packard, Executive Director of HERS Breast Cancer Foundation, has been invited by Silicon Valley Business Journal to participate as a mentor in their BizWomen: Mentoring Monday event on April 7. Fremont, Calif. (PRWEB) April 03, 2014 HERS Breast Cancer Foundation today announced that their Executive Director, Dr. Vera Packard, will participate as a mentor in Silicon Valley Business Journal’s national networking event on Monday, April 7. BizWomen: Mentoring Monday is an exciting...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related